Robyn T. Sussman

Convergence of Acquired Mutations and Alternative Splicing of <i>CD19</i> Enables Resistance to CART-19 Immunotherapy

Elena Sotillo, David M. Barrett, Kathryn L. Black et al. · Cancer Discovery · 2015 · 1.2K citations · Full text

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma

Kristopher R. Bosse, Pichai Raman, Zhongyu Zhu et al. · Cancer Cell · 2017 · 222 citations · Full text

Oncogenic Agent, Immunology, Pathology +8

USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression

Randy S. Schrecengost, Jeffry L. Dean, Jonathan F. Goodwin et al. · Cancer Research · 2013 · 131 citations · Full text

The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2)

Robyn T. Sussman, Timothy J. Stanek, Paul Esteso et al. · Journal of Biological Chemistry · 2013 · 88 citations · Full text

Chromatin, Transcriptional Regulation, Cell Lineage +13

Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the Non-SP, a higher expression of c-Myc and TRAIL-receptor DR4

Robyn T. Sussman, Margherita Ricci, Lori S. Hart et al. · Cancer Biology & Therapy · 2007 · 81 citations

Immunology, Cancer Biology, Tumor Biology +17